SAN

88.23

+0.88%↑

MRK1

114.95

-0.39%↓

SHL.DE

46.57

+0.34%↑

ARGX

515.4

+0.98%↑

ONC.US

254.35

-0.88%↓

SAN

88.23

+0.88%↑

MRK1

114.95

-0.39%↓

SHL.DE

46.57

+0.34%↑

ARGX

515.4

+0.98%↑

ONC.US

254.35

-0.88%↓

SAN

88.23

+0.88%↑

MRK1

114.95

-0.39%↓

SHL.DE

46.57

+0.34%↑

ARGX

515.4

+0.98%↑

ONC.US

254.35

-0.88%↓

SAN

88.23

+0.88%↑

MRK1

114.95

-0.39%↓

SHL.DE

46.57

+0.34%↑

ARGX

515.4

+0.98%↑

ONC.US

254.35

-0.88%↓

SAN

88.23

+0.88%↑

MRK1

114.95

-0.39%↓

SHL.DE

46.57

+0.34%↑

ARGX

515.4

+0.98%↑

ONC.US

254.35

-0.88%↓

Search

Fresenius SE & Co KGaA

Închisă

SectorSănătate

44.24 0.07

Rezumat

Modificarea prețului

24h

Curent

Minim

44.2

Maxim

44.39

Indicatori cheie

By Trading Economics

Venit

198M

471M

Vânzări

21M

5.7B

P/E

Medie Sector

23.257

51.198

Randament dividend

2.32

Marjă de profit

8.335

Angajați

175,202

EBITDA

225M

949M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+11.75% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

2.32%

2.40%

Următoarele câștiguri

6 aug. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

3.4B

24B

Deschiderea anterioară

44.17

Închiderea anterioară

44.24

Sentimentul știrilor

By Acuity

42%

58%

143 / 380 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Neutral Evidence

Fresenius SE & Co KGaA Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

7 mai 2025, 06:55 UTC

Market Talk
Câștiguri

Fresenius's Outlook Is Achievable -- Market Talk

26 feb. 2025, 13:37 UTC

Market Talk

European Stocks on Track for Record Close as Earnings Lift Mood -- Market Talk

Comparație

Modificare preț

Fresenius SE & Co KGaA Așteptări

Obiectiv de preț

By TipRanks

11.75% sus

Prognoză pe 12 luni

Medie 49.44 EUR  11.75%

Maxim 52 EUR

Minim 45 EUR

În baza a 13 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruFresenius SE & Co KGaA - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

13 ratings

11

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

42.5 / 43.2Suport & Rezistență

Termen scurt

Neutral Evidence

Termen mediu

Weak Bullish Evidence

Termen lung

Bullish Evidence

Sentiment

By Acuity

143 / 380 Clasament în Sănătate

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Fresenius SE & Co KGaA

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.